UNH · News · 20260730N

Q2 Results and Guidance

UNITEDHEALTH GROUP INC · 2026-07-30 · Importance 85 · Surprise 76

UnitedHealth Group reported second-quarter 2026 revenue of approximately $110 billion, representing 15% year-over-year growth driven by both UnitedHealthcare and Optum. Adjusted earnings per share increased, and the company raised or reaffirmed its full-year 2026 profit and revenue outlook after beating expectations. Improved medical cost management supported profitability, while continued dividends and share repurchases remained part of the capital-return program. The quarter also included financial effects from a 2026 Change Healthcare cyber incident, although the reported coverage did not quantify those costs.

Key facts

• ProQR Therapeutics will announce Q2 2026 earnings before market open on Thursday, August 6th, with an earnings call scheduled for August 11th. source
• Analysts project ProQR will report a loss of $0.14 per share on revenue of $4.56 million for Q2 2026. source
• Insiders purchased 600,000 shares of ProQR worth $988,500 over the past quarter. source
• Analysts maintain a "Moderate Buy" consensus rating on ProQR with a target price of $7.33. source